Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00345540
Status:
COMPLETED
Last Update Posted:
2015-03-10
First Post:
2006-06-26
Brief Title:
Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer
Sponsor:
Cellectar Biosciences Inc
Organization:
Cellectar Biosciences Inc
Organization Data
Organization:
Cellectar Biosciences Inc
Class:
INDUSTRY
Study ID:
NOV002- IS21 -OC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cellectar Biosciences Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dana-Farber Cancer Institute | OTHER |
| Massachusetts General Hospital | OTHER |